In Central Asia, Project HOPE is combating the burdens of tuberculosis, drug-resistant tuberculosis, and TB/HIV co-infection.
For more than 25 years, Project HOPE’s programs in Central Asia have improved health outcomes by training health care providers to address TB and HIV, delivering public health education, and responding in times of crisis. Throughout the region, we have:
Increased health systems’ capacities to address tuberculosis (TB), HIV/AIDS, and maternal, neonatal and child health
Strengthened laboratory systems through regional guidelines on quality management and rapid diagnostics
Reduced HIV/TB co-infection among most at-risk populations
Contributed to declines in TB mortality rates across the region
In Kazakhstan, HOPE is addressing cross-border TB, multidrug-resistant TB and TB/HIV co-infection among labor migrants. Program activities include conducting migrant-friendly outreach services and develop bilateral agreements for cross-border cooperation on TB control.
HOPE’s work in TB management has been recognized for its “Best Practices” in the area of Advocacy, Communication, and Social Mobilization by the World Health Organization (WHO). In addition, Project HOPE has published numerous articles in international journals and presented results of our work in Central Asia at the most renowned international conferences on TB.
Our History in Central Asia Our work in Central Asia began in 1990, providing rehabilitation and orthopedic support following an earthquake. In 1993, Project HOPE began our decades-long effort in Central Asia to improve TB control through an early pilot of the direct observed therapy (DOT) strategy in Kazakhstan. In 1999, we began working in maternal and child health and later expanded into HIV prevention work with schoolchildren in Russia.
As a result of our success in TB since 1993, Project HOPE has received multiple grants from donors such as USAID and the Global Fund Against TB, AIDS, and Malaria to continue our work in TB. Over the years, our TB portfolio expanded to also address multidrug-resistant TB and TB/HIV co-infection, spanning across all five Central Asian Republics.